Emerging Leaders Editorial: Maintaining Quality Requires “Quality Thinking”

Quality of thought is more than a philosophical ideal; it represents the caliber and precision of an individual’s thinking processes. It gauges how clearly, logically, and creatively we reason when faced with complex problems or when generating new ideas. This concept has ancient roots and has evolved throughout time by incorporating aspects of psychology (highlighting cognitive clarity and bias reduction), philosophy (emphasizing sound reasoning and critical analysis), and engineering (focused on systematic problem-solving).

It is closely related to both critical thinking (evaluating information and arguments methodically) and creative thinking (innovating and finding novel solutions). A high quality of thought means one’s cognitive approach is thorough, well-structured, and imaginative, laying a foundation for effective problem-solving and sound decision-making.

Some forms of thinking might be better suited for certain tasks. Kahneman’s cognitive model, for instance, differentiates intuitive (System 1) from reflective and analytical thinking (System 2), emphasizing the latter’s advantage for thoroughly addressing complex quality and regulatory scenarios.

However, the following general definition of quality thought applies to all scenarios: Focusing on high-quality thinking enables a culture of intellectual rigor, facilitating risk assessments, root cause analyses, and deviation handling as well as overall problem-solving. That rigor allows for successful actions like establishing preventive measures, continuously optimizing operations, and making on-point strategic decisions regarding project pipelines and investments.

Ronald Howard, the late Stanford University professor and pioneer in decision analysis said, “Clarity of action depends on quality of thought. You have to get your thinking straight before you can talk about making choices.” Pharmaceutical professionals must frequently deal with substantial regulatory documentation, data-rich clinical studies, and sometimes even mysterious quality issues. For companies in the pharmaceutical, biotechnology, and life sciences fields, it is worthwhile to invest in cognitive trainings because they equip employees and team members with superior analytical skills, significantly reducing cognitive biases that could lead to regulatory oversights or quality deficiencies. To outline this, I would like to share a few examples of what is already being undertaken by today’s industry.

Mandatory AI Training

This year Johnson & Johnson implemented mandatory training for AI usage, ensuring widespread AI literacy within the organization. We could think about implementing structured critical thinking methodologies like the Paul-Elder framework as well, guiding professionals to assess their cognitive processes rigorously against intellectual standards such as clarity, precision, depth, logic, and fairness.

Creative Problem-Solving

Companies like Pfizer help foster creative problem-solving using methods like design thinking to encourage patient-centered innovation and compliance solutions. Another robust alternative is the theory of inventive problem solving (TRIZ), which has demonstrated effectiveness in improving adverse event reporting, deviation management, and precision medicine innovation.

Games and Challenges

Eli Lilly’s AI Games and ISPE’s Hackathons are examples of organizations offering games and challenges that inspire innovation and critical thinking. Lev-eraging humans’ competitive nature is a playful way to get people passionate about current issues and familiarized with existing tools.

Focus Time

Another option is enforcing focus times, like Takeda’s meeting-free Fridays. Institute structured “deep-thinking sessions,” free from interruptions, to enable focused evaluation of complex regulatory documents, risk assessments, and quality strategies. Case studies in the pharmaceutical industry have validated this approach, linking enhanced cognitive quality with improved regulatory outcomes and quality assurance.

Agile Organizational Structures

Creating agile organizational structures like Bayer’s Dynamic Shared Ownership model is another successful example. Flat hierarchies and dynamic team configurations promote individual accountability and decision-making, enhancing the collective quality of thought.

A Competitive Factor

What initiatives is your organization or ISPE Chapter implementing to nurture the quality of thought? How can each professional contribute to fostering a cognitively rigorous environment? In the pharmaceutical context, quality of thought is far more than a buzzword—it is a decisive competitive factor. Scientific definitions from psychology and cognitive research make “good thinking” tangible. Its importance is evident every day in pharmaceutical practice, where the power to innovate and solve problems determines success.

Proven methods allow companies to nurture high-quality thinking deliberately, and best-practice examples show how such a mindset can be embedded in corporate culture. Multiple studies confirm the effectiveness of these approaches. Investing in superior thinking—through training, culture, and organizational structures—pays off in better ideas, more efficient processes, and, ultimately, more successful therapies for patients.

“Quality is never an accident; it is always the result of high intention, sincere effort, intelligent direction and skillful execution. It represents the wise choice of many alternatives,” author unknown (this quote is commonly attributed to the World War II veteran and Medal of Honor recipient William A. Foster or early 20^th century economist William Trufant Foster).

Learn More